ZURA BIO LIMITEDEquity Incentive Plan Share Option Agreement • August 22nd, 2022 • JATT Acquisition Corp • Biological products, (no disgnostic substances)
Unless otherwise defined herein, the terms defined in the 2022 Equity Incentive Plan (the “Plan”) shall have the same defined meanings in this Share Option Agreement (the “Option Agreement”). This Option Agreement is made pursuant to the shareholder approval of the adoption by the Company of the Plan and the Board approval of the option awards, each granted on 8 June 2022.
INDEMNITY AGREEMENTIndemnity Agreement • August 22nd, 2022 • JATT Acquisition Corp • Biological products, (no disgnostic substances) • New York
THIS INDEMNITY AGREEMENT (the “Agreement”) is made and entered into as of [______], 2021 between Zura Bio Limited, a Cayman Islands exempted company (the “Company”), and the undersigned indemnified party (“Indemnitee”).
INVESTMENT AGREEMENTInvestment Agreement • August 22nd, 2022 • JATT Acquisition Corp • Biological products, (no disgnostic substances) • Delaware
This Investment Agreement (the “Agreement”) is made and entered into on this 20th day of February, 2022 (the “Effective Date”), by and between Hana Immunotherapeutics LLC, a Delaware company (“Hana”), and Zura Bio, Ltd, a UK limited company (“Zura”).
SPONSOR FORFEITURE AGREEMENTSponsor Forfeiture Agreement • August 22nd, 2022 • JATT Acquisition Corp • Biological products, (no disgnostic substances)
This Sponsor Forfeiture Agreement (this “Agreement”) is entered into as of June 16, 2022, by and among JATT Ventures, L.P., a Cayman Islands exempted company (the “Sponsor”), JATT Acquisition Corp, a Cayman Islands exempted company (“SPAC”) and Zura Bio Limited, a limited company incorporated under the laws of England and Wales (the “Company). Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Business Combination Agreement (as defined below).
CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) THE TYPE THAT THE REGISTRANT NORMALLY TREATS AS PRIVATE AND CONFIDENTIAL. LICENSE AGREEMENTLicense Agreement • August 22nd, 2022 • JATT Acquisition Corp • Biological products, (no disgnostic substances) • New York
THIS LICENSE AGREEMENT (“Agreement”) is made effective as of the __ day of ________, 2022 (the “Effective Date”), by and between Zura Bio Limited, a company organized and existing under the laws of England whose registered office is at 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, UK, WA14 (“Licensee”) and Pfizer Inc., a corporation organized and existing under the laws of Delaware with offices at 235 East 42nd Street, New York, New York 10017 (“Pfizer”). Licensee and Pfizer may, from time-to-time, be individually referred to as a “Party” and collectively referred to as the “Parties”.
